Can Music Mend Minds? Investigating The Mechanisms Underlying The Beneficial Effects Of Music On Persons With Dementia
Funder
National Health and Medical Research Council
Funding Amount
$411,108.00
Summary
Music can have positive effects on persons with dementia. It be a powerful trigger of memories and emotions and provide a link to one's personal past and a form of communication with carers. Familiar songs can be recognised even in the late stages of dementia when verbal communication and memory for other things may be lost. There has been little scientific investigation of how and why music can help people with dementia and their carers. This research will address this issue.
The Missing Link: MGluR5 As A Therapeutic Target For Cognitive Decline In Dementia
Funder
National Health and Medical Research Council
Funding Amount
$563,622.00
Summary
Cognitive decline is a core feature of Alzheimer’s Disease (AD), yet there is no cure or treatment. Recent evidence suggests that a protein called mGluR5 could cause brain cells to lose function, leading to memory loss. This project will investigate whether disrupting mGluR5 function can improve cognition in mice with genetic AD. Memory will be assessed in mice using innovative touchscreen tests that closely mimic the tests used in humans.
Protecting Synaptic Connectivity In Alzheimer's Disease
Funder
National Health and Medical Research Council
Funding Amount
$573,573.00
Summary
In Alzheimer’s disease, connections between neurons (synapses) are progressively damaged. The BACE inhibitor class of drugs entering Phase III clinical trials may slow the pace of neurodegeneration in patients with dementia. However, these drugs may simultaneously have negative effects on synapse function, learning and memory. This study will assess the effect of BACE inhibition on synapse properties and cognition and identify the contribution of key proteins affected by this treatment.
Spatial Learning And Memory In Huntington's Disease
Funder
National Health and Medical Research Council
Funding Amount
$475,969.00
Summary
This project will develop a spatial learning and memory test battery sensitive to dementia in Huntington’s disease, relate the task to atrophy in key brain regions, and then apply the test in a clinical trial aimed at developing a regeneration of damaged brain regions in Huntington’s disease. The overarching goal is to develop a cognitive test that is closely aligned to brain pathology in dementia as a tool for more precise, mechanism-based investigations in the dementia clinical trial setting.
Targeting G-quadruplex DNA As A Novel Therapeutic Strategy For Alzheimer’s And Frontotemporal Dementia
Funder
National Health and Medical Research Council
Funding Amount
$720,144.00
Summary
Dementia is the third leading cause of death in Australia and there is an urgent need to identify new ways of treating diseases that cause dementia. Our research is focused on targeting an unusual DNA structure in Alzheimer’s and Frontotemporal dementia (FTD). We will use a precision-targeted technology to better control formation of this DNA structure in disease-causing genes, allowing us to switch off the gene and hence stop disease progression for Alzheimer’s and FTD.
Sleep, Plasticity And Neurodegeneration: Targeting Sleep To Improve Cognition In Mild Cognitive Impairment (MCI)
Funder
National Health and Medical Research Council
Funding Amount
$525,116.00
Summary
Older individuals with mild cognitive impairment commonly experience disturbed sleep and about 50% will convert to dementia. It is unclear whether sleep disturbance mediates cognitive decline and progression to dementia. Optimising sleep presents a novel strategy to slow disease progression. This new research program explores links between sleep and dementia to identify new biomarkers of disease progression and new targeted therapeutic approaches to improve quality of life for older Australians.
Predicting Perioperative Cognitive Disorders In The Elderly Based On Cardiovascular Risk, AD Risk And New Biomarkers
Funder
National Health and Medical Research Council
Funding Amount
$471,826.00
Summary
Anaesthesia and surgery are common in the elderly and are known to lead to memory and thinking problems. Why this happens is unclear. I plan to study confusion, memory and thinking problems before and after surgery and to determine if blood or cerebrospinal fluid tests or modifying cardiovascular disease can predict this happening. This work will lead to early identification of people who are at risk of cognitive problems following anaesthesia and surgery, and ways to prevent this happening.
Harnessing Lipid-reactive Immunity To Combat Mycobacterium Tuberculosis Infection
Funder
National Health and Medical Research Council
Funding Amount
$341,458.00
Summary
Critcial to the survival of Mycobacterium tuberculosis, the causative agent of tuberculosis (TB) is its unique waxy (lipid)-rich cell wall. This proposal aims to target components of its cell wall to devlop novel therapeutic strategies. Specifically, the Australian-Singapore alliance will examine how the immune system "sees" lipid based antigens from M. tuberculosis, and then will ultimately use this information towards the devlopment of novel lipid-based vaccines.
What Can Tau Deposition Tell Us About The Appearance Of Subjective And Objective Cognitive Decline In Older Adults?
Funder
National Health and Medical Research Council
Funding Amount
$674,077.00
Summary
Subjective memory concerns are common in older adults, but it is uncertain how they relate to Alzheimer’s disease (AD) biomarkers. Novel neuroimaging techniques have been developed for measuring tau deposition, a hallmark feature of AD. Using this technique, I aim to determine whether tau is sensitive to certain types of subjective concerns. My findings will reveal which concerns are indicative of AD risk, and which arise from unrelated factors, such as inattention or stress.
Dementia is an urgent global challenge with enormous health and economic cost to Australia. While the hope is for a cure, the number with dementia is growing and diagnosis is often delayed by ~3 years. This project will use innovative neurocognitive methods to achieve earlier diagnosis and develop tailored treatments. This will enhance or maintain function, promoting independence and community living, improving the quality of life and care for persons living with dementia.